Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Pain, Postoperative 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Prostatic Neoplasms 3 Myoma 3 Leiomyoma 3 Head and Neck Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Agnosia 3 Stomatitis 2 Skin Neoplasms 2 Postoperative Hemorrhage 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Hemorrhage 2 Fatigue 2 Colonic Neoplasms 2 Chronic Pain 2 Carcinoma, Hepatocellular 2 Water-Electrolyte Imbalance 1 Vulvodynia 1 Uterine Cervical Neoplasms 1

Interventions

Microbial Collagenase 13 xiapex 10 Collagenases 4 Triamcinolone Acetonide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Oxycodone 1 Injections, Intra-Articular 1 Ibuprofen 1 High-Energy Shock Waves 1 Enzymes 1 Arthroplasty, Replacement, Shoulder 1 Arthroplasty, Replacement, Elbow 1 Adalimumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dupuytren Contracture × Sodium Chloride × Clear all

NCT03180957 2024-06-28

RIDD

University of Oxford

Phase 2 Completed

140 enrolled 29 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon ⚡